AVADEL PHARMACEUTICALS PLC's ticker is AVDL and the CUSIP is 05337M104. A total of 101 filers reported holding AVADEL PHARMACEUTICALS PLC in Q3 2023. The put-call ratio across all filers is 0.37 and the average weighting 0.4%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Carmichael Hill & Associates, Inc. | 21,000 | $216,300 | 0.10% |
| Soleus Capital Management, L.P. | 104,000 | $1,071,200 | 0.10% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 45,586 | $469,536 | 0.10% |
| State of Wyoming | 41,801 | $430,550 | 0.09% |
| Blue Zone Wealth Advisors, LLC | 16,000 | $164,800 | 0.07% |
| JANUS HENDERSON GROUP PLC | 10,638,307 | $109,601,329 | 0.07% |
| J. Goldman & Co LP | 163,382 | $1,682,835 | 0.06% |
| SILVERBACK ASSET MANAGEMENT LLC | 100,000 | $290,000 | 0.04% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 1,725,000 | $17,767,500 | 0.04% |
| Aaron Wealth Advisors LLC | 22,642 | $233,213 | 0.03% |
| Jump Financial, LLC | 53,571 | $551,781 | 0.02% |
| Virtu Financial LLC | 20,047 | $206 | 0.02% |
| Cetera Advisors LLC | 87,871 | $905,071 | 0.01% |
| Caption Management, LLC | 81,100 | $835,330 | 0.01% |
| Renaissance Technologies | 738,906 | $7,611 | 0.01% |
| MARSHALL WACE, LLP | 460,803 | $4,746,273 | 0.01% |
| Carmichael Hill & Associates, Inc. | 2,000 | $20,600 | 0.01% |
| OPPENHEIMER & CO INC | 39,911 | $411,083 | 0.01% |
| MAI Capital Management | 45,223 | $465,797 | 0.01% |
| China Universal Asset Management Co., Ltd. | 2,298 | $24 | 0.01% |
External links
This page lists AVADEL PHARMACEUTICALS PLC's shareholders in Q3 2023. To view AVADEL PHARMACEUTICALS PLC's shareholder history, click here.